Skip to main content

PFIZER INC

corporate_fare Company Profile

PFIZER INC

PFE·NYSE·Life Sciences·CIK 0000078003

Pfizer Inc. is a research-based, global biopharmaceutical company that discovers, develops, manufactures, markets, sells, and distributes biopharmaceutical products worldwide. The company applies science and global resources to provide therapies that extend and significantly improve lives. Pfizer operates in both developed and emerging markets, focusing on wellness, prevention, treatments, and cures for significant diseases. It collaborates with healthcare providers, governments, and local communities to support and expand access to reliable, affordable healthcare globally. Incorporated in Delaware on June 2, 1942, Pfizer generates most of its revenues from the manufacture and sale of biopharmaceutical products. The company aims to enhance the value of its medicines and vaccines and works with patients, physicians, and payors to prevent and treat disease and improve outcomes. Pfizer evaluates its pricing arrangements and contracting methods with payors to maximize patient access while minimizing adverse impacts on revenues within current legal and pricing structures.

PFIZER INC (NYSE:PFE) is a publicly traded company in the Life Sciences sector. Wiseek monitors PFE SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Pfizer Exceeds Q1 Revenue and EPS Estimates, Reaffirms Full-Year Outlook
  • Pfizer Issues FY26 Adjusted EPS Guidance of $2.80-$3.00
  • Pfizer Extends Vyndamax Patent to 2031, Securing Revenue Stability
  • Pfizer Wins 3-Year Tariff Exemption, Faces Drug Supply Discounts, Closes $7B Metsera Buy
  • Trump Administration Prepares 100-200% Tariffs on Drugmakers Without Price Deals

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$62.58B
Net Income
$7.77B
Diluted EPS
$1.36
Op. Cash Flow
$11.7B
Free Cash Flow
$9.07B
Gross Profit
$46.51B
Cash & Equivalents
$1.14B
Total Debt
$64.64B
Debt / Equity
0.75×
Net Margin
12.4%
Shares Outstanding
5.68B sh
Source: 10-K · filed 2026-02-26 · accession 0000078003-26-000026
$24.74 +0.02% today
52-week range · as of 2026-06-18 $23.11 – $28.75
Market cap
$140.89B
Volume
82M (2.1× avg)
3-mo avg 38.7M
Live data · 2026-06-24 03:17 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed PFE - Filings & News (Page 2)

PFE
May 05, 2026, 6:56 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $26.35
Real-time Price: $24.74 info
Change: -$1.61 (-6%) info
Market Cap: $140.89B info
PFE
May 05, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $26.44
Real-time Price: $24.74 info
Change: -$1.70 (-6%) info
Market Cap: $140.89B info
PFE
Apr 28, 2026, 10:26 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $26.64
Real-time Price: $24.74 info
Change: -$1.89 (-7%) info
Market Cap: $140.89B info
PFE
Apr 02, 2026, 4:05 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $28.33
Real-time Price: $24.74 info
Change: -$3.58 (-13%) info
Market Cap: $140.89B info
PFE
Apr 01, 2026, 11:25 PM EDT
Source: CNBC TV18
Importance Score:
7
Price at Filing: $28.55
Real-time Price: $24.74 info
Change: -$3.81 (-13%) info
Market Cap: $140.89B info
PFE
Apr 01, 2026, 4:09 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $28.54
Real-time Price: $24.74 info
Change: -$3.80 (-13%) info
Market Cap: $140.89B info
PFE
Mar 23, 2026, 12:46 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $26.77
Real-time Price: $24.74 info
Change: -$2.02 (-8%) info
Market Cap: $140.89B info
PFE
Mar 23, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $26.65
Real-time Price: $24.74 info
Change: -$1.91 (-7%) info
Market Cap: $140.89B info
PFE
Mar 12, 2026, 9:05 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $27.15
Real-time Price: $24.74 info
Change: -$2.41 (-9%) info
Market Cap: $140.89B info
PFE
Mar 09, 2026, 7:11 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $26.65
Real-time Price: $24.74 info
Change: -$1.91 (-7%) info
Market Cap: $140.89B info
PFE
Mar 02, 2026, 11:09 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $27.40
Real-time Price: $24.74 info
Change: -$2.66 (-10%) info
Market Cap: $140.89B info
PFE
Feb 26, 2026, 12:44 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $27.03
Real-time Price: $24.74 info
Change: -$2.28 (-8%) info
Market Cap: $140.89B info
PFE
Feb 03, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $26.41
Real-time Price: $24.74 info
Change: -$1.67 (-6%) info
Market Cap: $140.89B info